13.94 USD
-0.01 (-0.07%)
At close: Jan 30, 2026
13.94 USD
0 (0%)
After Hours: 1/30/2026, 8:23:36 PM
Overall VREX gets a fundamental rating of 5 out of 10. We evaluated VREX against 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of VREX get a neutral evaluation. Nothing too spectacular is happening here. VREX has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year VREX was profitable.
- VREX had a positive operating cash flow in the past year.
- In multiple years VREX reported negative net income over the last 5 years.
- VREX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -6.35%, VREX is in the better half of the industry, outperforming 65.76% of the companies in the same industry.
- The Return On Equity of VREX (-14.88%) is better than 64.13% of its industry peers.
- VREX has a Return On Invested Capital of 5.67%. This is in the better half of the industry: VREX outperforms 77.72% of its industry peers.
- VREX had an Average Return On Invested Capital over the past 3 years of 4.82%. This is below the industry average of 8.81%.
- The last Return On Invested Capital (5.67%) for VREX is above the 3 year average (4.82%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.35% | ||
| ROE | -14.88% | ||
| ROIC | 5.67% |
ROA(3y)-2.14%
ROA(5y)-0.47%
ROE(3y)-5.1%
ROE(5y)-1.2%
ROIC(3y)4.82%
ROIC(5y)5.54%
1.3 Margins
- VREX has a better Operating Margin (7.83%) than 75.00% of its industry peers.
- VREX's Operating Margin has declined in the last couple of years.
- VREX has a Gross Margin of 34.40%. This is in the lower half of the industry: VREX underperforms 74.46% of its industry peers.
- VREX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.83% | ||
| PM (TTM) | N/A | ||
| GM | 34.4% |
OM growth 3Y-8.19%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5Y5.76%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VREX is destroying value.
- Compared to 1 year ago, VREX has more shares outstanding
- The number of shares outstanding for VREX has been increased compared to 5 years ago.
- The debt/assets ratio for VREX has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 1.99 indicates that VREX is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 1.99, VREX is doing good in the industry, outperforming 60.33% of the companies in the same industry.
- VREX has a debt to FCF ratio of 19.87. This is a negative value and a sign of low solvency as VREX would need 19.87 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 19.87, VREX is in the better half of the industry, outperforming 70.11% of the companies in the same industry.
- VREX has a Debt/Equity ratio of 0.79. This is a neutral value indicating VREX is somewhat dependend on debt financing.
- The Debt to Equity ratio of VREX (0.79) is worse than 70.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.79 | ||
| Debt/FCF | 19.87 | ||
| Altman-Z | 1.99 |
ROIC/WACC0.55
WACC10.28%
2.3 Liquidity
- A Current Ratio of 3.43 indicates that VREX has no problem at all paying its short term obligations.
- With a decent Current ratio value of 3.43, VREX is doing good in the industry, outperforming 61.41% of the companies in the same industry.
- A Quick Ratio of 1.83 indicates that VREX should not have too much problems paying its short term obligations.
- The Quick ratio of VREX (1.83) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.43 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
- VREX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.00%, which is quite impressive.
- Measured over the past years, VREX shows a very strong growth in Earnings Per Share. The EPS has been growing by 57.78% on average per year.
- Looking at the last year, VREX shows a small growth in Revenue. The Revenue has grown by 4.14% in the last year.
- Measured over the past years, VREX shows a small growth in Revenue. The Revenue has been growing by 2.73% on average per year.
EPS 1Y (TTM)60%
EPS 3Y-14.54%
EPS 5Y57.78%
EPS Q2Q%94.74%
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-0.58%
Revenue growth 5Y2.73%
Sales Q2Q%11.28%
3.2 Future
- The Earnings Per Share is expected to grow by 7.66% on average over the next years.
- VREX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.03% yearly.
EPS Next Y-0.32%
EPS Next 2Y7.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.92%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 15.84 indicates a correct valuation of VREX.
- Compared to the rest of the industry, the Price/Earnings ratio of VREX indicates a rather cheap valuation: VREX is cheaper than 88.59% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of VREX to the average of the S&P500 Index (28.30), we can say VREX is valued slightly cheaper.
- Based on the Price/Forward Earnings ratio of 15.89, the valuation of VREX can be described as correct.
- 87.50% of the companies in the same industry are more expensive than VREX, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 25.57. VREX is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.84 | ||
| Fwd PE | 15.89 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, VREX is valued cheaper than 94.02% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, VREX is valued a bit cheaper than 78.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.92 | ||
| EV/EBITDA | 8.47 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.27
EPS Next 2Y7.66%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- VREX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
VAREX IMAGING CORP / VREX FAQ
What is the fundamental rating for VREX stock?
ChartMill assigns a fundamental rating of 5 / 10 to VREX.
What is the valuation status of VAREX IMAGING CORP (VREX) stock?
ChartMill assigns a valuation rating of 5 / 10 to VAREX IMAGING CORP (VREX). This can be considered as Fairly Valued.
What is the profitability of VREX stock?
VAREX IMAGING CORP (VREX) has a profitability rating of 5 / 10.
How financially healthy is VAREX IMAGING CORP?
The financial health rating of VAREX IMAGING CORP (VREX) is 5 / 10.
What is the expected EPS growth for VAREX IMAGING CORP (VREX) stock?
The Earnings per Share (EPS) of VAREX IMAGING CORP (VREX) is expected to decline by -0.32% in the next year.